Role of ET(B) receptors in local clearance of endothelin-1 in rat heart: Studies with the antagonists PD 155080 and BQ-788

被引:47
作者
Brunner, F [1 ]
Doherty, AM [1 ]
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT CHEM,ANN ARBOR,MI 48105
关键词
endothelin-1; coronary resistance; tissue clearance; ET(B) subtype; clearance receptor;
D O I
10.1016/0014-5793(96)01103-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of two endothelin (ET) receptor antagonists, PD 155080 (ET(A) selective) and BQ-788 (ET(B) selective), on cardiac function and ET-I release were studied in isolated rat hearts, In normoxic hearts, infusion of PD 155080 (50 nM-5 mu M) reduced coronary resistance, but had no effect on ET-1 release, Lon concentrations of BQ-788 (2 and 20 nM) had no effect on coronary resistance; high concentrations (0.2 and 2 mu M) increased it similar to 2-fold; all concentrations increased ET-1 release (up to 24-fold), Similar results were obtained in reperfused hearts, Although concentrations of ET-I were higher in interstitial fluid than coronary effluent, levels never exceeded the low pg/ml range. These results indicate that (1) ET(A) receptors mediate coronary constriction, whereas ET(B) receptors bind and sequester ET-1, and (2) ET-1 displaced by ET(B) antagonist accesses ET(A) receptors resulting in coronary constriction.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 27 条
[1]   TISSUE ENDOTHELIN-1 LEVELS IN PERFUSED RAT-HEART FOLLOWING STIMULATION WITH AGONISTS AND IN ISCHEMIA AND REPERFUSION [J].
BRUNNER, F .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (09) :1953-1963
[2]   BINDING OF ENDOTHELIN TO PLASMA-PROTEINS AND TISSUE RECEPTORS - EFFECTS ON ENDOTHELIN DETERMINATION, VASOACTIVITY, AND TISSUE KINETICS [J].
BRUNNER, F ;
STESSEL, H ;
WATZINGER, N ;
LOFFLER, BM ;
OPIE, LH .
FEBS LETTERS, 1995, 373 (01) :97-101
[3]   ENDOTHELIN AT PATHOPHYSIOLOGICAL CONCENTRATIONS MEDIATES CORONARY VASOCONSTRICTION VIA THE ENDOTHELIN-A RECEPTOR [J].
CANNAN, CR ;
BURNETT, JC ;
BRANDT, RR ;
LERMAN, A .
CIRCULATION, 1995, 92 (11) :3312-3317
[4]   DESIGN OF A FUNCTIONAL HEXAPEPTIDE ANTAGONIST OF ENDOTHELIN [J].
CODY, WL ;
DOHERTY, AM ;
HE, JX ;
DEPUE, PL ;
RAPUNDALO, ST ;
HINGORANI, GA ;
MAJOR, TC ;
PANEK, RL ;
DUDLEY, DT ;
HALEEN, SJ ;
LADOUCEUR, D ;
HILL, KE ;
FLYNN, MA ;
REYNOLDS, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (17) :3301-3303
[5]   DISCOVERY OF A NOVEL SERIES OF ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN-A (ET(A)) RECEPTOR-SELECTIVE ANTAGONISTS [J].
DOHERTY, AM ;
PATT, WC ;
EDMUNDS, JJ ;
BERRYMAN, KA ;
REISDORPH, BR ;
PLUMMER, MS ;
SHAHRIPOUR, A ;
LEE, C ;
CHENG, XM ;
WALKER, DM ;
HALEEN, SJ ;
KEISER, JA ;
FLYNN, MA ;
WELCH, KM ;
HALLAK, H ;
TAYLOR, DG ;
REYNOLDS, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (08) :1259-1263
[6]   CLEARANCE OF CIRCULATING ENDOTHELIN-1 BY ET(B) RECEPTORS IN RATS [J].
FUKURODA, T ;
FUJIKAWA, T ;
OZAKI, S ;
ISHIKAWA, K ;
YANO, M ;
NISHIKIBE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) :1461-1465
[7]   EFFECTS OF ENDOTHELIN-1 AND THE ET(A)-RECEPTOR ANTAGONIST, BQ123, ON ISCHEMIC ARRHYTHMIAS IN ANESTHETIZED RATS [J].
GARJANI, A ;
WAINWRIGHT, CL ;
ZEITLIN, IJ ;
WILSON, C ;
SLEE, SJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (04) :634-642
[8]  
GROVER GJ, 1992, J PHARMACOL EXP THER, V263, P1074
[9]   ENDOTHELIN AND MYOCARDIAL-ISCHEMIA [J].
HASDAI, D ;
KORNOWSKI, R ;
BATTLER, A .
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (04) :589-599
[10]   Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans [J].
Haynes, WG ;
Ferro, CJ ;
OKane, KPJ ;
Somerville, D ;
Lomax, CC ;
Webb, DJ .
CIRCULATION, 1996, 93 (10) :1860-1870